|
MarketWire
|
|
Wednesday, 23 May 2012 14:20 |
SAGINAW, MI--Trim Holding Group (the "Company") (PINKSHEETS: TRHG) (OTCQB: TRHG) is pleased to announce that effective as of May 22, 2012, the Company amended its Articles of Incorporation for the sole purpose of changing its name from Trim Holding Group to HPIL Holding.
|
|
Read more...
|
|
PRNewsWire
|
|
Wednesday, 23 May 2012 12:34 |
PITTSBURGH--Mylan Inc. (Nasdaq: MYL) today reported that Moody's Investors Service ("Moody's") has upgraded the company's credit ratings, including the "Corporate Family Rating," to Ba1 from Ba2. Following this action, Moody's rating outlook is stable.
|
|
Read more...
|
|
Latest News
|
|
Tuesday, 22 May 2012 18:55 |
|
ATLANTA--GeoVax Labs, Inc. (otcqb/otcbb:GOVX), an Atlanta-based biopharmaceutical firm developing vaccines to prevent and fight Human Immunodeficiency Virus (HIV) infections, today announced that the NIH-funded HIV Vaccine Trials Network (HVTN) has opened enrollment for a Phase 1 trial for the company's second-generation HIV vaccine.
|
|
Read more...
|
|
Business Wire
|
|
Tuesday, 24 January 2012 14:16 |
|
|
|
Read more...
|
|
Breaking News
|
|
Monday, 29 August 2011 00:15 |
VILNIUS, Lithuania -- Neurotechnology, a provider of high-precision biometric and object identification technologies, today announced the availability of SentiSight 3.0, a Software Development Kit (SDK) for universal object recognition.
|
|
Read more...
|
|
MarketWire
|
|
Wednesday, 23 May 2012 13:16 |
EDISON, NJ--The Plastic and Reconstructive Surgery journal recently published an article that reports that brow and facelift surgeries like forehead lift have the potential to treat migraines.
|
|
Read more...
|
|
PRNewsWire
|
|
Wednesday, 23 May 2012 10:44 |
|
WAGENINGEN, The Netherlands--Micreos of The Netherlands has attracted additional capital for accelerated growth of its phage business. Altria Ventures, the strategic investment arm of Altria Group, has acquired a 5% stake in Micreos, viewed as global leader in phage technology for targeted control of bacteria.
|
|
Read more...
|
|
Latest News
|
|
Thursday, 03 May 2012 11:19 |
|
CALGARY, AB--Oncolytics Biotech Inc. (“Oncolytics”) (TSX:ONC, NASDAQ:ONCY) announced today that it has entered into an agreement whereby the NCIC Clinical Trials Group (CTG) at Queen's University in Kingston, Ontario, will sponsor and conduct a randomized Phase II study of REOLYSIN® in patients with advanced or metastatic colorectal cancer.
|
|
Read more...
|
|
Business Wire
|
|
Tuesday, 24 January 2012 12:41 |
REDWOOD CITY, CA--Avinger, Inc., a medical device manufacturer of innovative, multi-functional catheters for treating patients with Peripheral Artery Disease (PAD), announces two live Ocelot cases will be transmitted by Professor Giovanni Torsello and Dr. Arne Schwindt from St. Franziskus Hospital to an expert panel and live audience at the Leipzig Interventional Course (LINC) 2012 conference in Leipzig, Germany on Friday, January 27 at 3:00 p.m. CET.
|
|
Read more...
|
|
Breaking News
|
|
Sunday, 28 August 2011 23:15 |
LAS VEGAS -- Cord Blood America, Inc. (OTC Bulletin Board:CBAI) announced today it has entered into an agreement with BancoVida (www.bancovida.com) to offer umbilical cord blood collection services in Puerto Rico and throughout the Caribbean.
|
|
Read more...
|
|
|